Bioavailability
Measurement of bioavailability




                    Presented by,
                    Pradip.L.Ghori
                    M-Pharm 1st year
                    Dept. of Pharmaceutics


                                             1
Measurement of bioavailability

   Pharmacokinetic methods ( indirect )
    1. Blood analysis
    2. Urinary excretion data


   Pharmacodynamic methods ( direct )
    1. Acute pharmacological response
    2. Therapeutic response




                                           2
Blood analysis
   Plasma level time studies or The plasma concentration –
    time curve or blood level curve.

   A direct relationship exists concentration of drug at the
    site of action & concentration of drug in the plasma.

   Serial blood samples are taken after drug administration
    & analyzed for drug concentration.

   A typical blood level curve obtained after oral
    administration of drug.



                                                              3
4
Parameters determined
        Pharmacokinetic parameters
   Peak Plasma Concentration (Cmax)
   Time of Peak concentration (tmax).
   Area Under Curve (AUC)

        Pharmacodynamics parameters
   Minimum Effective Concentration (MEC) / Minimum
    Inhibitory Concentration (MIC).
   Maximum Safe Concentration (MSC) / Maximum Safe
    Dose (MSD).
   Duration of action
   Onset of action.
   Intensity of action.
                                                      5
     AUC or Extent of absorption can be measured by 3
      methods…
1.Planimeter
     Instrument for mechanically measuring the area

2. Cut & weigh method
    AUC is cut & weighed on analytical balance. The weight
     obtained is converted to proper unit by dividing it by
     the wt of a unit area of same paper.

3. Trapezoidal method


                                                              6
3. Trapezoidal method



AUC = ½ ( C1 + C2) (t2 – t1) + ½ (C2 + C3) (t3 – t2) +…….
           ½ (C   n-1   + C n ) (tn – tn-1 )


       C = Concentration
       t = time
       subscript= sample number
       AUC = Area Under Curve



                                                            7
Relative bioavailability

F rel =   ( AUC)   drug   . (Dose) standard
           (AUC)    standard   .(Dose)       drug




Absolute bioavailability

Fab =     (AUC)drug . (Dose)          IV

           (AUC)IV . (Dose)           drug
                                                    8
Urinary excretion data

   The method of determination bioavailability provided
    that the active ingredient is excreted unchanged in the
    significant quantity of urine.

   The cumulative amount of active drug excreted in urine
    is directly proportional to extent of systemic drug
    absorption.

   The rate of drug excretion is directly proportional to
    rate of systemic drug absorption.




                                                              9
Advantages

   Useful when there is lack of sufficiently sensitive
    analytical techniques to measure concentration of drug
    in plasma.
   Noninvasive method therefore better subject
    compliance.
   Convenience of collecting urine samples in comparison to
    drawing of blood periodically.
   If any case the urine drug concentration is low, assaying
    of larger sample volume is relatively more.
   Direct measurement of bioavailability, both absolute &
    relative is possible without the necessity of fitting the
    data to the mathematical model.

                                                                10
11
   Bioavailability is determined by….



F= (U             )   oral   .D   IV

        (U        )   IV     .D   oral



    U           = Cumulative amt of unchanged drug excreted in
                     urine
    D   IV     = IV dose
    D   oral   = oral dose
          F = absolute bioavailability
                                                                 12
   When equal doses are administered Intravenously &
    Orally…..



F = (U     )    oral

      (U    )      IV




F = (U      )      test

      (U       )    standard




                                                        13
   When drug A was administered IV to a group of volunteers, 80%
    of the 500mg dose was recovered unchanged in the urine. When
    the same drug was administered to the same volunteers
    orally.280 mg was recovered unchanged in urine. What is the
    absolute bioavailability of Drug A following oral administration.


Absolute bioavailability = (cumulative amt.of drug excreted) sample
                              (cumulative amt.of drug excreted)IV


                          =   280
                              400
                          = 0.7 or 70%
                                                                      14
Acute pharmacological response

   Bioavailability can be determined from the acute
    pharmacologic effect – time curve as well as from
    dose response graph.

   DISADVANTAGE is that pharmacological response
    tends to more variable & accurate correlation
    between the measured response & drug available
    from the formulation is difficult.




                                                        15
Therapeutic response
   This method is based on the observing the clinical
    response to a drug formulation given to a patients
    suffering from disease for which it is intended to be
    used.

   Ex …for anti inflammatory drugs, the reduction in the
    inflammation is determined.

   The major DRAWBACK is …quantification of observed
    response is too improper to allow for reasonable
    assessment of relative bioavailability between two
    dosage forms of a same drug.


                                                            16
References
   “Biopharmaceutics & pharmacokinetics”, D.M.
    Brahmankar & Sunil B. Jaiswal, Vallabh prakashan.

   “Text book of Biopharmaceutics & pharmacokinetics”,
    Dr.Shobharani R. Hiramath.

   “Applied Biopharmaceutics & pharmacokinetics”, Leon
    Shargel & Andrew B.C.

   www.google.com




                                                          17
Thank you…….!!!




 Any
 questions….?

                  18

More Related Content

PPTX
sustained release drug delivery system
PPT
Hepatic clearance and elimination
PPTX
Controlled drug delivery system part II
PPTX
one compartment model ppt
PPTX
Ocular drug delivery system & ocuserts
PPTX
METHOD OF RESIDUALS
PPTX
Physicochemical Properties effect on Absorption of Drugs
PPTX
P h partition hypothesis
sustained release drug delivery system
Hepatic clearance and elimination
Controlled drug delivery system part II
one compartment model ppt
Ocular drug delivery system & ocuserts
METHOD OF RESIDUALS
Physicochemical Properties effect on Absorption of Drugs
P h partition hypothesis

What's hot (20)

PPTX
Theories of Dissolution
PDF
Introduction to biopharmaceutics
PPTX
Controlled drug delivery systems
PPTX
Drug distribution system in Hospital
PDF
Pharmacokinetic models
PPTX
pH partition theory of drug absorption
PPTX
Approaches Of Gastro-Retentive Drug Delivery System or GRDDS
PPTX
Methods For Assesment Of Bioavailability
PPTX
Mechanism of drug absorption in git
PPTX
Factors affecting drug absorption
PPTX
IN VITRO - IN VIVO CORRELATION
PPTX
Transdermal drug delivery system
PPT
Microencapsulation (2)
PPTX
Dissolution
PPTX
Pharmacokinetic models
PPTX
Approaches to Targeted Delivery of Drugs
PPTX
Drug Dissolution
PPT
A seminar on one & two compartment open model extra vascular administration
PPTX
bioavailability & bioequivalence
PDF
Polymers in controlled release Drug Delivery System
Theories of Dissolution
Introduction to biopharmaceutics
Controlled drug delivery systems
Drug distribution system in Hospital
Pharmacokinetic models
pH partition theory of drug absorption
Approaches Of Gastro-Retentive Drug Delivery System or GRDDS
Methods For Assesment Of Bioavailability
Mechanism of drug absorption in git
Factors affecting drug absorption
IN VITRO - IN VIVO CORRELATION
Transdermal drug delivery system
Microencapsulation (2)
Dissolution
Pharmacokinetic models
Approaches to Targeted Delivery of Drugs
Drug Dissolution
A seminar on one & two compartment open model extra vascular administration
bioavailability & bioequivalence
Polymers in controlled release Drug Delivery System
Ad

Viewers also liked (9)

PPTX
Estimation of pharmacokinetic parameters
PPTX
Bioavailability and bioequivalence lecture
PPT
Methods of Assessing Bioavailability
PPT
Bioavailability Studies
PPTX
Bioavailability, Bioequivalence and BCS Classification
PPT
Pharmacology bioavailability
PPT
Bioavailability ppt
PPTX
Bioavailability and Bioequivalence Studies
PPTX
Aerosols
Estimation of pharmacokinetic parameters
Bioavailability and bioequivalence lecture
Methods of Assessing Bioavailability
Bioavailability Studies
Bioavailability, Bioequivalence and BCS Classification
Pharmacology bioavailability
Bioavailability ppt
Bioavailability and Bioequivalence Studies
Aerosols
Ad

Similar to Bioavailability by pradip (20)

PPTX
Methods of assesment of BA & BE , Design and evaluation , Study desgn.pptx
PPTX
bioavailability studies in biopharmaceutics
PPTX
BIO AVAILABILITY & Bio equivalence.pptx
PPTX
Bioavailability and bioequivalence of Drug Productppt2.pptx
PPTX
Bioavailability and bioequivalence of Drug Productppt2.pptx
PPTX
Bioavailability and bioequivalence of Drug Productppt2.pptx
PPTX
Bioavailability , absolute bioavalability, relative bioavailability, Purpose ...
PPTX
Bioavailability study
PPTX
Bioavailability-Kinetics.pptx
PPT
Bioavailibility 112070804016
PPTX
Bioavailability and bioeqivalance testing
PDF
-Bioavailability and Bioequivalence-.pdf
PPTX
Bioavailability And Bioequivalence
PPT
Measurement of bioavailability and concept of equivalence
PDF
BioavailabilityandBioequivalence.pdf
PPT
PHARMACY Bioavailability & Bioequivalance.ppt
PPTX
Bioavailability
PDF
BIOAVAILABILITY IN A NUTSHELL.pdf
PPT
Chapter08 - 10 Bioavailability & Bioequivalance.ppt
PPTX
Measurements of bioavailability
Methods of assesment of BA & BE , Design and evaluation , Study desgn.pptx
bioavailability studies in biopharmaceutics
BIO AVAILABILITY & Bio equivalence.pptx
Bioavailability and bioequivalence of Drug Productppt2.pptx
Bioavailability and bioequivalence of Drug Productppt2.pptx
Bioavailability and bioequivalence of Drug Productppt2.pptx
Bioavailability , absolute bioavalability, relative bioavailability, Purpose ...
Bioavailability study
Bioavailability-Kinetics.pptx
Bioavailibility 112070804016
Bioavailability and bioeqivalance testing
-Bioavailability and Bioequivalence-.pdf
Bioavailability And Bioequivalence
Measurement of bioavailability and concept of equivalence
BioavailabilityandBioequivalence.pdf
PHARMACY Bioavailability & Bioequivalance.ppt
Bioavailability
BIOAVAILABILITY IN A NUTSHELL.pdf
Chapter08 - 10 Bioavailability & Bioequivalance.ppt
Measurements of bioavailability

Recently uploaded (20)

PPTX
abgs and brain death dr js chinganga.pptx
DOCX
ORGAN SYSTEM DISORDERS Zoology Class Ass
PPT
intrduction to nephrologDDDDDDDDDy lec1.ppt
PPTX
Indications for Surgical Delivery...pptx
PPTX
PRE ECLAPSIA AND ECLAPSIA presentation-1.pptx
PDF
FMCG-October-2021........................
PPTX
Hypertensive disorders in pregnancy.pptx
PPSX
Man & Medicine power point presentation for the first year MBBS students
PPT
fiscal planning in nursing and administration
PPTX
Pharynx and larynx -4.............pptx
PPTX
CASE PRESENTATION CLUB FOOT management.pptx
PPTX
01. cell injury-2018_11_19 -student copy.pptx
PDF
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
PPTX
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PDF
periodontaldiseasesandtreatments-200626195738.pdf
PPTX
AWMI case presentation ppt AWMI case presentation ppt
PPTX
SEMINAR 6 DRUGS .pptxgeneral pharmacology
PPTX
Type 2 Diabetes Mellitus (T2DM) Part 3 v2.pptx
PPTX
Tuberculosis : NTEP and recent updates (2024)
PPTX
sexual offense(1).pptx download pptx ...
abgs and brain death dr js chinganga.pptx
ORGAN SYSTEM DISORDERS Zoology Class Ass
intrduction to nephrologDDDDDDDDDy lec1.ppt
Indications for Surgical Delivery...pptx
PRE ECLAPSIA AND ECLAPSIA presentation-1.pptx
FMCG-October-2021........................
Hypertensive disorders in pregnancy.pptx
Man & Medicine power point presentation for the first year MBBS students
fiscal planning in nursing and administration
Pharynx and larynx -4.............pptx
CASE PRESENTATION CLUB FOOT management.pptx
01. cell injury-2018_11_19 -student copy.pptx
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
periodontaldiseasesandtreatments-200626195738.pdf
AWMI case presentation ppt AWMI case presentation ppt
SEMINAR 6 DRUGS .pptxgeneral pharmacology
Type 2 Diabetes Mellitus (T2DM) Part 3 v2.pptx
Tuberculosis : NTEP and recent updates (2024)
sexual offense(1).pptx download pptx ...

Bioavailability by pradip

  • 1. Bioavailability Measurement of bioavailability Presented by, Pradip.L.Ghori M-Pharm 1st year Dept. of Pharmaceutics 1
  • 2. Measurement of bioavailability  Pharmacokinetic methods ( indirect ) 1. Blood analysis 2. Urinary excretion data  Pharmacodynamic methods ( direct ) 1. Acute pharmacological response 2. Therapeutic response 2
  • 3. Blood analysis  Plasma level time studies or The plasma concentration – time curve or blood level curve.  A direct relationship exists concentration of drug at the site of action & concentration of drug in the plasma.  Serial blood samples are taken after drug administration & analyzed for drug concentration.  A typical blood level curve obtained after oral administration of drug. 3
  • 4. 4
  • 5. Parameters determined Pharmacokinetic parameters  Peak Plasma Concentration (Cmax)  Time of Peak concentration (tmax).  Area Under Curve (AUC) Pharmacodynamics parameters  Minimum Effective Concentration (MEC) / Minimum Inhibitory Concentration (MIC).  Maximum Safe Concentration (MSC) / Maximum Safe Dose (MSD).  Duration of action  Onset of action.  Intensity of action. 5
  • 6. AUC or Extent of absorption can be measured by 3 methods… 1.Planimeter Instrument for mechanically measuring the area 2. Cut & weigh method AUC is cut & weighed on analytical balance. The weight obtained is converted to proper unit by dividing it by the wt of a unit area of same paper. 3. Trapezoidal method 6
  • 7. 3. Trapezoidal method AUC = ½ ( C1 + C2) (t2 – t1) + ½ (C2 + C3) (t3 – t2) +……. ½ (C n-1 + C n ) (tn – tn-1 ) C = Concentration t = time subscript= sample number AUC = Area Under Curve 7
  • 8. Relative bioavailability F rel = ( AUC) drug . (Dose) standard (AUC) standard .(Dose) drug Absolute bioavailability Fab = (AUC)drug . (Dose) IV (AUC)IV . (Dose) drug 8
  • 9. Urinary excretion data  The method of determination bioavailability provided that the active ingredient is excreted unchanged in the significant quantity of urine.  The cumulative amount of active drug excreted in urine is directly proportional to extent of systemic drug absorption.  The rate of drug excretion is directly proportional to rate of systemic drug absorption. 9
  • 10. Advantages  Useful when there is lack of sufficiently sensitive analytical techniques to measure concentration of drug in plasma.  Noninvasive method therefore better subject compliance.  Convenience of collecting urine samples in comparison to drawing of blood periodically.  If any case the urine drug concentration is low, assaying of larger sample volume is relatively more.  Direct measurement of bioavailability, both absolute & relative is possible without the necessity of fitting the data to the mathematical model. 10
  • 11. 11
  • 12. Bioavailability is determined by…. F= (U ) oral .D IV (U ) IV .D oral U = Cumulative amt of unchanged drug excreted in urine D IV = IV dose D oral = oral dose F = absolute bioavailability 12
  • 13. When equal doses are administered Intravenously & Orally….. F = (U ) oral (U ) IV F = (U ) test (U ) standard 13
  • 14. When drug A was administered IV to a group of volunteers, 80% of the 500mg dose was recovered unchanged in the urine. When the same drug was administered to the same volunteers orally.280 mg was recovered unchanged in urine. What is the absolute bioavailability of Drug A following oral administration. Absolute bioavailability = (cumulative amt.of drug excreted) sample (cumulative amt.of drug excreted)IV = 280 400 = 0.7 or 70% 14
  • 15. Acute pharmacological response  Bioavailability can be determined from the acute pharmacologic effect – time curve as well as from dose response graph.  DISADVANTAGE is that pharmacological response tends to more variable & accurate correlation between the measured response & drug available from the formulation is difficult. 15
  • 16. Therapeutic response  This method is based on the observing the clinical response to a drug formulation given to a patients suffering from disease for which it is intended to be used.  Ex …for anti inflammatory drugs, the reduction in the inflammation is determined.  The major DRAWBACK is …quantification of observed response is too improper to allow for reasonable assessment of relative bioavailability between two dosage forms of a same drug. 16
  • 17. References  “Biopharmaceutics & pharmacokinetics”, D.M. Brahmankar & Sunil B. Jaiswal, Vallabh prakashan.  “Text book of Biopharmaceutics & pharmacokinetics”, Dr.Shobharani R. Hiramath.  “Applied Biopharmaceutics & pharmacokinetics”, Leon Shargel & Andrew B.C.  www.google.com 17
  • 18. Thank you…….!!! Any questions….? 18